拖网 发表于 2025-3-25 05:12:12

Submitted on: 23 September 2003.
Revised on: 06 October 2003.
Accepted on: 16 October 2003.
NUCLEAR MEDICINE REVIEW---VIA MEDICA

玛瑙 发表于 2025-3-25 11:26:46

Submitted on: 06 September 2017.
Revised on: 16 October 2017.
Accepted on: 31 October 2017.
NUCLEAR MEDICINE REVIEW---VIA MEDICA

Between 发表于 2025-3-25 12:43:30

Submitted on: 21 October 2002.
Revised on: 25 November 2002.
Accepted on: 23 December 2002.
NUCLEAR MEDICINE REVIEW

effrontery 发表于 2025-3-25 16:46:22

http://reply.papertrans.cn/3/234/23367/23367-24.png

600 发表于 2025-3-25 21:39:28

Submitted on: 05 May 2010.
Revised on: 31 May 2010.
Accepted on: 06 June 2010.
NUCLEAR MEDICINE REVIEW

无关紧要 发表于 2025-3-26 03:49:14

http://reply.papertrans.cn/3/234/23367/23367-26.png

pellagra 发表于 2025-3-26 05:59:06

http://reply.papertrans.cn/3/234/23367/23367-27.png

condemn 发表于 2025-3-26 09:20:02

http://reply.papertrans.cn/3/234/23367/23367-28.png

防锈 发表于 2025-3-26 14:30:38

http://reply.papertrans.cn/3/234/23367/23367-29.png

投票 发表于 2025-3-26 18:28:00

Submitted on: 02 February 2011.
Revised on: 16 March 2011.
Accepted on: 28 March 2011.
NUCLEAR MEDICINE REVIEW---VIA MEDICA
页: 1 2 [3] 4
查看完整版本: ESCI期刊NUCLEAR MEDICINE REVIEW 2024/2025影响因子:0.625 (NUCL MED REV) (1506-9680). (RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IM